Cytosorbents (CTSO) Reaches $10.65 After 8.00% Down Move; 2 Bullish Analysts Covering Red Lion Hotels (RLH)

June 22, 2018 - By Linda Rogers

Cytosorbents Corporation (NASDAQ:CTSO) Logo

Among 2 analysts covering Red Lion Hotels (NYSE:RLH), 2 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Red Lion Hotels had 9 analyst reports since August 6, 2015 according to SRatingsIntel. The stock has “Buy” rating by B. Riley & Co on Tuesday, August 1. The stock of Red Lion Hotels Corporation (NYSE:RLH) earned “Buy” rating by Zacks on Thursday, August 6. The stock of Red Lion Hotels Corporation (NYSE:RLH) earned “Buy” rating by B. Riley & Co on Monday, October 30. The firm earned “Buy” rating on Wednesday, March 7 by FBR Capital. FBR Capital maintained it with “Buy” rating and $14.5000 target in Wednesday, April 18 report. On Friday, January 26 the stock rating was maintained by FBR Capital with “Buy”. The company was maintained on Thursday, March 29 by FBR Capital. The rating was maintained by FBR Capital with “Buy” on Thursday, November 30. The stock of Red Lion Hotels Corporation (NYSE:RLH) earned “Buy” rating by FBR Capital on Wednesday, May 9. See Red Lion Hotels Corporation (NYSE:RLH) latest ratings:

09/05/2018 Broker: FBR Capital Rating: Buy New Target: $14.5000 Maintain
18/04/2018 Broker: FBR Capital Rating: Buy New Target: $14.5000 Maintain
29/03/2018 Broker: FBR Capital Rating: Buy New Target: $14.5000 Maintain
07/03/2018 Broker: FBR Capital Rating: Buy New Target: $14.5 Maintain
26/01/2018 Broker: FBR Capital Rating: Buy New Target: $13.75 Maintain

The stock of Cytosorbents Corporation (NASDAQ:CTSO) is a huge mover today! The stock decreased 3.18% or $0.35 during the last trading session, reaching $10.65. About 87,799 shares traded. Cytosorbents Corporation (NASDAQ:CTSO) has risen 156.32% since June 22, 2017 and is uptrending. It has outperformed by 143.75% the S&P500. Some Historical CTSO News: 17/05/2018 – CYTOSORBENTS CORP CTSO.O : COWEN AND COMPANY RAISES TARGET PRICE TO $11 FROM $9; 09/04/2018 – CytoSorbents to Meet With European Investors at the H.C. Wainwright Annual Global Life Sciences Conference in Monte Carlo and in Meetings in Frankfurt, Geneva and Zurich; 28/03/2018 – CytoSorbents Reports on the Successful 5th International CytoSorb Users Meeting and 38th ISICEM Critical Care Conference; 08/03/2018 – Cytosorbents 2017 Loss/Shr 32c; 21/05/2018 – CytoSorbents Presenting at Conference May 23; 14/05/2018 – CytoSorb® Adds Bilirubin and Myoglobin Reduction to European Union Approved Indications for Use; 23/03/2018 – CytoSorbents Access Event Set By LifeSci Advisors for Mar. 28; 28/03/2018 – CytoSorbents at Non-Deal Roadshow Hosted By LifeSci Advisors; 08/03/2018 – CYTOSORBENTS CORP CTSO.O : COWEN AND COMPANY RAISES TARGET PRICE TO $9 FROM $7; 20/04/2018 – DJ CytoSorbents Corporation, Inst Holders, 1Q 2018 (CTSO)The move comes after 9 months negative chart setup for the $319.96 million company. It was reported on Jun, 22 by Barchart.com. We have $9.80 PT which if reached, will make NASDAQ:CTSO worth $25.60M less.

More notable recent Red Lion Hotels Corporation (NYSE:RLH) news were published by: Globenewswire.com which released: “RLH Corporation Appoints Gary Sims Chief Operating Officer” on June 06, 2018, also Globenewswire.com with their article: “RLH Corporation Promotes Paul Sacco to Executive Vice President, President of Global Development” published on June 18, 2018, Globenewswire.com published: “RLH Corporation Increases Group Commission to 11%” on May 24, 2018. More interesting news about Red Lion Hotels Corporation (NYSE:RLH) were released by: Globenewswire.com and their article: “Coliseum Capital Management and Vindico Capital Acquire RLH Corporation Shares Previously Held by HNA …” published on June 15, 2018 as well as Globenewswire.com‘s news article titled: “RLH Corporation Promotes Amanda Marcello to Senior Vice President of Brand Strategy” with publication date: June 13, 2018.

Red Lion Hotels Corporation, a hospitality and leisure company, owns, manages, and franchises hotels under its Hotel RL, Red Lion Hotel, Red Lion Inn & Suites, GuestHouse, and Settle Inn & Suites brands primarily in the United States. The company has market cap of $278.43 million. The firm operates through three divisions: Franchised Hotels, Company Operated Hotels, and Entertainment. It has a 676.47 P/E ratio. It also promotes and presents entertainment productions under the WestCoast Entertainment name.

Since May 23, 2018, it had 0 insider purchases, and 9 sales for $50.37 million activity. $281,829 worth of Red Lion Hotels Corporation (NYSE:RLH) shares were sold by MCKEIRNAN THOMAS L. Another trade for 10,000 shares valued at $112,700 was sold by Mount Gregory T. Another trade for 488,037 shares valued at $5.10M was made by Coliseum Capital Management – LLC on Friday, June 15. Another trade for 3.74M shares valued at $39.07 million was sold by HNA Investment Management LLC. Columbia Pacific Opportunity Fund – L.P. sold $1.48M worth of stock.

The stock decreased 1.29% or $0.15 during the last trading session, reaching $11.5. About 40,191 shares traded. Red Lion Hotels Corporation (NYSE:RLH) has risen 58.14% since June 22, 2017 and is uptrending. It has outperformed by 45.57% the S&P500. Some Historical RLH News: 07/05/2018 – RED LION HOTELS CORP – ON MAY 1, UNIT ENTERED INTO AMENDED, RESTATED PURCHASE DEAL WITH KNIGHTS FRANCHISE SYSTEMS, WYNDHAM HOTEL GROUP, AMONG OTHERS; 06/03/2018 RLH Corporation Closes Sale of Three Additional Hotels for $29.9 Million; 14/05/2018 – RED LION HOTELS CORP – FUNDS FROM $30 MLN TERM LOAN WILL BE PRIMARILY USED FOR PREVIOUSLY ANNOUNCED KNIGHTS INN ACQUISITION; 23/04/2018 – RED LION HOTELS CORP – COMMITMENT AUTOMATICALLY TERMINATES ON MAY 31, 2018 IF COMPANY HAS NOT CLOSED LOAN PRIOR TO THAT DATE; 07/05/2018 – RED LION HOTELS CORP – CONSISTENT WITH ORIGINAL AGREEMENT, AGGREGATE PURCHASE PRICE REMAINS $27 MLN; 04/04/2018 – Red Lion Hotels to Acquire Brand for $27M Cas; 15/05/2018 – The Island by Hotel RL Opens in Fort Walton Beach, Florida; 22/05/2018 – Red Lion Hotels: Bloss and Moyle Will End Employment With Co Effective May 31; 17/04/2018 – Red Lion Controls Adds PID Controller Capabilities for Complete HMI Solution; 04/04/2018 – RED LION HOTELS CORP – DEAL FOR AN AGGREGATE PRICE OF $27 MLN CASH

Investors sentiment decreased to 0.97 in 2018 Q1. Its down 1.08, from 2.05 in 2017Q4. It worsened, as 9 investors sold Red Lion Hotels Corporation shares while 21 reduced holdings. 12 funds opened positions while 17 raised stakes. 15.27 million shares or 3.27% less from 15.79 million shares in 2017Q4 were reported. California State Teachers Retirement reported 0% of its portfolio in Red Lion Hotels Corporation (NYSE:RLH). Northern Trust Corporation holds 0% or 200,213 shares in its portfolio. Washington Trust Natl Bank invested 0.1% of its portfolio in Red Lion Hotels Corporation (NYSE:RLH). Moreover, Tiaa Cref Inv Ltd Llc has 0% invested in Red Lion Hotels Corporation (NYSE:RLH) for 45,011 shares. Adirondack Research And Management Inc, New York-based fund reported 61,097 shares. Moreover, Segall Bryant Hamill Ltd Liability Corp has 0.11% invested in Red Lion Hotels Corporation (NYSE:RLH). 202,100 are held by Bridgeway Cap Mgmt Incorporated. State Street invested in 236,488 shares or 0% of the stock. Wellington Llp holds 0% of its portfolio in Red Lion Hotels Corporation (NYSE:RLH) for 1.00M shares. Royal Natl Bank Of Canada invested in 0% or 51,910 shares. 91,447 are held by Deutsche National Bank & Trust Ag. The Massachusetts-based Portolan Cap Ltd Liability Corp has invested 0.64% in Red Lion Hotels Corporation (NYSE:RLH). Moreover, Goldman Sachs Grp has 0% invested in Red Lion Hotels Corporation (NYSE:RLH) for 15,685 shares. Vanguard Group invested in 753,288 shares. Eidelman Virant reported 991,600 shares.

More news for Cytosorbents Corporation (NASDAQ:CTSO) were recently published by: Benzinga.com, which released: “Benzinga’s Daily Biotech Pulse: Hematology Conference In The Spotlight, Dr. Reddy To Launch Generic Opioid …” on June 15, 2018. Prnewswire.com‘s article titled: “CytoSorbents to Present at the Jefferies 2018 Global Healthcare Conference” and published on June 04, 2018 is yet another important article.

Since January 8, 2018, it had 0 buys, and 11 selling transactions for $1.06 million activity. $92,202 worth of Cytosorbents Corporation (NASDAQ:CTSO) was sold by BLOCH KATHLEEN P.. 4,846 shares were sold by Capponi Vincent, worth $43,614 on Wednesday, May 16.

CytoSorbents Corporation, a critical care focused immunotherapy company, engages in the research, development, and commercialization of medical devices with its platform blood purification technology incorporating a proprietary adsorbent, porous polymer technology. The company has market cap of $319.96 million. The Company’s principal product is CytoSorb device, an extracorporeal cytokine filter designed for the adjunctive therapy in the treatment of sepsis; adjunctive therapy in other critical care applications; prevention and treatment of post-operative complications of cardiopulmonary bypass surgery; and prevention and treatment of organ dysfunction in brain-dead organ donors to increase the number and quality of viable organs harvested from donors. It currently has negative earnings. The firm also provides VetResQ device for adjunctive therapy in the treatment of sepsis, pancreatitis, and other critical illnesses in animals.

Analysts await Cytosorbents Corporation (NASDAQ:CTSO) to report earnings on August, 6. They expect $-0.13 earnings per share, down 225.00% or $0.09 from last year’s $-0.04 per share. After $-0.10 actual earnings per share reported by Cytosorbents Corporation for the previous quarter, Wall Street now forecasts 30.00% negative EPS growth.

Cytosorbents Corporation (NASDAQ:CTSO) Institutional Positions Chart

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our FREE daily email newsletter:


Recent Posts

>